109 related articles for article (PubMed ID: 8031997)
21. Differential regulation of chemokines by leukemia inhibitory factor, interleukin-6 and oncostatin M.
Hartner A; Goppelt-Struebe M; Hocke GM; Sterzel RB
Kidney Int; 1997 Jun; 51(6):1754-60. PubMed ID: 9186863
[TBL] [Abstract][Full Text] [Related]
22. Selection and characterization of a variant of human melanoma cell line, A375 resistant to growth inhibitory effects of oncostatin M (OM): coresistant to interleukin 6 (IL-6).
McDonald VL; Dick KO; Malik N; Shoyab M
Growth Factors; 1993; 9(3):167-75. PubMed ID: 8274294
[TBL] [Abstract][Full Text] [Related]
23. Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells.
Muszynski KW; Ruscetti FW; Heidecker G; Rapp U; Troppmair J; Gooya JM; Keller JR
J Exp Med; 1995 Jun; 181(6):2189-99. PubMed ID: 7539043
[TBL] [Abstract][Full Text] [Related]
24. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway.
Ray DW; Ren SG; Melmed S
J Clin Invest; 1996 Apr; 97(8):1852-9. PubMed ID: 8621768
[TBL] [Abstract][Full Text] [Related]
25. Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions.
Lu C; Rak JW; Kobayashi H; Kerbel RS
Cancer Res; 1993 Jun; 53(12):2708-11. PubMed ID: 8504408
[TBL] [Abstract][Full Text] [Related]
26. Interactions between oncostatin M and the IL-6 signal transducer, gp130.
Liu J; Modrell B; Aruffo A; Scharnowske S; Shoyab M
Cytokine; 1994 May; 6(3):272-8. PubMed ID: 8054483
[TBL] [Abstract][Full Text] [Related]
27. Oncostatin M induces angiogenesis in vitro and in vivo.
Vasse M; Pourtau J; Trochon V; Muraine M; Vannier JP; Lu H; Soria J; Soria C
Arterioscler Thromb Vasc Biol; 1999 Aug; 19(8):1835-42. PubMed ID: 10446061
[TBL] [Abstract][Full Text] [Related]
28. Leukaemia inhibitory factor and interleukin 6 inhibit secretion of prolactin and growth hormone by rat pituitary MtT/SM cells.
Tomida M; Yoshida U; Mogi C; Maruyama M; Goda H; Hatta Y; Inoue K
Cytokine; 2001 May; 14(4):202-7. PubMed ID: 11448119
[TBL] [Abstract][Full Text] [Related]
29. Are LIF and related cytokines functionally equivalent?
Piquet-Pellorce C; Grey L; Mereau A; Heath JK
Exp Cell Res; 1994 Aug; 213(2):340-7. PubMed ID: 8050491
[TBL] [Abstract][Full Text] [Related]
30. Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells.
Brown TJ; Lioubin MN; Marquardt H
J Immunol; 1987 Nov; 139(9):2977-83. PubMed ID: 3117884
[TBL] [Abstract][Full Text] [Related]
31. Leukaemia inhibitory factor and oncostatin M modulate expression of urokinase plasminogen activator and fibrinogen.
Okada H; Woodcock-Mitchell J; Fujii S
Coron Artery Dis; 1996 Aug; 7(8):561-7. PubMed ID: 8922882
[TBL] [Abstract][Full Text] [Related]
32. Glycoprotein 130 ligand oncostatin-M induces expression of vascular endothelial growth factor in human adult cardiac myocytes.
Weiss TW; Speidl WS; Kaun C; Rega G; Springer C; Macfelda K; Losert UM; Grant SL; Marro ML; Rhodes AD; Fuernkranz A; Bialy J; Ullrich R; Holzmann P; Pacher R; Maurer G; Huber K; Wojta J
Cardiovasc Res; 2003 Sep; 59(3):628-38. PubMed ID: 14499864
[TBL] [Abstract][Full Text] [Related]
33. Soluble glycoprotein 130 (gp130) attenuates OSM- and LIF-induced cartilage proteoglycan catabolism.
Hui W; Bell M; Carroll G
Cytokine; 2000 Feb; 12(2):151-5. PubMed ID: 10671300
[TBL] [Abstract][Full Text] [Related]
34. Distinct roles of oncostatin M and leukemia inhibitory factor in the development of primordial germ cells and sertoli cells in mice.
Hara T; Tamura K; de Miguel MP; Mukouyama Y; Kim Hj; Kogo H; Donovan PJ; Miyajima A
Dev Biol; 1998 Sep; 201(2):144-53. PubMed ID: 9740655
[TBL] [Abstract][Full Text] [Related]
35. Modulation of LIF expression in human melanoma cells by oncostatin M.
Heymann D; Blanchard F; Raher S; De Groote D; Godard A
Immunol Lett; 1995 Jun; 46(3):245-51. PubMed ID: 7590943
[TBL] [Abstract][Full Text] [Related]
36. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae.
Palmqvist P; Persson E; Conaway HH; Lerner UH
J Immunol; 2002 Sep; 169(6):3353-62. PubMed ID: 12218157
[TBL] [Abstract][Full Text] [Related]
37. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor.
Gearing DP; Comeau MR; Friend DJ; Gimpel SD; Thut CJ; McGourty J; Brasher KK; King JA; Gillis S; Mosley B
Science; 1992 Mar; 255(5050):1434-7. PubMed ID: 1542794
[TBL] [Abstract][Full Text] [Related]
38. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
[TBL] [Abstract][Full Text] [Related]
39. Oncostatin M (OSM) stimulates resorption and inhibits synthesis of proteoglycan in porcine articular cartilage explants.
Hui W; Bell M; Carroll G
Cytokine; 1996 Jun; 8(6):495-500. PubMed ID: 8818547
[TBL] [Abstract][Full Text] [Related]
40. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130.
Zhang XG; Gu JJ; Lu ZY; Yasukawa K; Yancopoulos GD; Turner K; Shoyab M; Taga T; Kishimoto T; Bataille R
J Exp Med; 1994 Apr; 179(4):1337-42. PubMed ID: 8145045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
